- Home
- FBRX vs SANG Comparison
FBRX vs SANG Comparison
Compare FBRX & SANG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- FBRX
- SANG
- Stock Information
- Founded
- FBRX N/A
- SANG 1984
- Country
- FBRX United States
- SANG Canada
- Employees
- FBRX N/A
- SANG N/A
- Industry
- FBRX Biotechnology: Pharmaceutical Preparations
- SANG Computer Software: Programming Data Processing
- Sector
- FBRX Health Care
- SANG Technology
- Exchange
- FBRX Nasdaq
- SANG Nasdaq
- Market Cap
- FBRX 170.0M
- SANG 168.6M
- IPO Year
- FBRX N/A
- SANG 2021
- Fundamental
- Price
- FBRX $18.56
- SANG $5.12
- Analyst Decision
- FBRX Strong Buy
- SANG
- Analyst Count
- FBRX 3
- SANG 0
- Target Price
- FBRX $68.00
- SANG N/A
- AVG Volume (30 Days)
- FBRX 108.4K
- SANG 4.9K
- Earning Date
- FBRX 11-14-2025
- SANG 11-10-2025
- Dividend Yield
- FBRX N/A
- SANG N/A
- EPS Growth
- FBRX N/A
- SANG N/A
- EPS
- FBRX N/A
- SANG N/A
- Revenue
- FBRX N/A
- SANG $227,360,000.00
- Revenue This Year
- FBRX N/A
- SANG N/A
- Revenue Next Year
- FBRX N/A
- SANG $5.68
- P/E Ratio
- FBRX N/A
- SANG N/A
- Revenue Growth
- FBRX N/A
- SANG N/A
- 52 Week Low
- FBRX $4.90
- SANG $4.08
- 52 Week High
- FBRX $28.68
- SANG $7.99
- Technical
- Relative Strength Index (RSI)
- FBRX 66.60
- SANG 51.21
- Support Level
- FBRX $18.11
- SANG $4.90
- Resistance Level
- FBRX $21.99
- SANG $5.37
- Average True Range (ATR)
- FBRX 1.78
- SANG 0.15
- MACD
- FBRX 0.70
- SANG 0.02
- Stochastic Oscillator
- FBRX 73.74
- SANG 59.02
About FBRX Forte Biosciences Inc.
Forte Biosciences Inc is a biopharmaceutical company that is advancing through preclinical trials its product candidate, FB-102, which is a proprietary therapeutic molecule with potentially broad autoimmune applications in such indications as graft-versus-host disease (GvHD), vitiligo, alopecia areata, and type 1 diabetes (T1D).
About SANG Sangoma Technologies Corporation
Sangoma Technologies Corp is a provider of hardware and software components that enable or enhance Internet Protocol Communications Systems for both telecom and datacom applications. It is engaged in the development, manufacturing, distribution, and support of voice and data connectivity components for software-based communication applications. Its product includes data and telecom boards for media and signal processing, as well as gateway appliances and software. The Company sells into two geographic centers: USA and Other countries. Key revenue is generated from USA.